검색어 : 통합검색[Robins Elizabeth.]
총 343건 중 343건 출력
, 26/35 페이지
-
251
- HLA class II-Restricted CD8+ T cells in HIV-1 Virus Controllers
- Nyanhete, Tinashe E.; Frisbee, Alyse L.; Bradley, Todd; Faison, William J.; Robins, Elizabeth; Payne, Tamika; Freel, Stephanie A.; Sawant, Sheetal; Weinhold, Kent J.; Wiehe, Kevin; Haynes, Barton F.; Ferrari, Guido; Li, Qi-Jing; Moody, M. Anthony; Tomaras, Georgia D.; ; (Scientific reports, v.9, 2019, pp.10165)
-
252
- Acute Time to Response in the Treatment for Adolescents With Depression Study (TADS)
- KRATOCHVIL, CHRISTOPHER; EMSLIE, GRAHAM; SILVA, SUSAN; McNULTY, STEVE; WALKUP, JOHN; CURRY, JOHN; REINECKE, MARK; VITIELLO, BENEDETTO; ROHDE, PAUL; FEENY, NORA; CASAT, CHARLES; PATHAK, SANJEEV; WELLER, ELIZABETH; MAY, DIANE; MAYES, TARYN; ROBINS, MICHELE; MARCH, JOHN; ; (Journal of the American Academy of Child and Adolescent Psychiatry, v.45, 2006, pp.1412-1418)
-
253
- Prevalence of Structural Central Nervous System Abnormalities in Early-Onset Type 1 Diabetes Mellitus
- Ho, Margaret S.; Weller, Narelle J.; Ives, F. Jay; Carne, Christine L.; Murray, Katherine; vanden Driesen, Rohan I.; Nguyen, Thai P.; Robins, Peter D.; Bulsara, Max; Davis, Elizabeth A.; Jones, Timothy W.; ; (The Journal of pediatrics, v.153, 2008, pp.385-390)
-
254
- ICAM-1 and IL-10 are associated with cognitive dysfunction using the MoCA test in glioma: Findings from the NCI Neuro-Oncology Branch Natural History Study
- Slattery, Kaitlynn; Kauss, McKenzie C; Raval, Dhaivat; Hsieh, Emory; Choi, Ann; Davis, Tara S; Robins, Kimberly R; Miller, Hope; Vera, Elizabeth; Wright, Michelle L; Penas-Prado, Marta; Gilbert, Mark R; Mendoza, Tito; Armstrong, Terri S; Guedes, Vivian A; National Cancer Institute Neuro-Oncology Branch, National Institutes of Health (NIH) , Bethesda, Maryland,; National Cancer Institute Neuro-Oncology Branch, National Institutes of Health (NIH) , Bethesda, Maryland,; National Cancer Institute Neuro-Oncology Branch, National Institutes of Health (NIH) , Bethesda, Maryland,; National Cancer Institute Neuro-Oncology Branch, National Institutes of Health (NIH) , Bethesda, Maryland,; National Cancer Institute Neuro-Oncology Branch, National Institutes of Health (NIH) , Bethesda, Maryland,; National Cancer Institute Neuro-Oncology Branch, National Institutes of Health (NIH) , Bethesda, Maryland,; National Cancer Institute Neuro-Oncology Branch, National Institutes of Health (NIH) , Bethesda, Maryland,; National Cancer Institute Neuro-Oncology Branch, National Institutes of Health (NIH) , Bethesda, Maryland,; National Cancer Institute (NCI) Office of Patient-Centered Outcomes Research, National Institutes of Health (NIH) , Bethesda, Ma; (Neuro-oncology advances, v.7, 2025, pp.vdaf002)
-
255
- Adiposity, Cardiometabolic Risk, and Vitamin D Status: The Framingham Heart Study
- Cheng, Susan; Massaro, Joseph M.; Fox, Caroline S.; Larson, Martin G.; Keyes, Michelle J.; McCabe, Elizabeth L.; Robins, Sander J.; O'Donnell, Christopher J.; Hoffmann, Udo; Jacques, Paul F.; Booth, Sarah L.; Vasan, Ramachandran S.; Wolf, Myles; Wang, Thomas J.; Framingham Heart Study, Framingham, Massachusetts; ; Framingham Heart Study, Framingham, Massachusetts; ; Framingham Heart Study, Framingham, Massachusetts; ; Framingham Heart Study, Framingham, Massachusetts; ; Framingham Heart Study, Framingham, Massachusetts; ; Framingham Heart Study, Framingham, Massachusetts; ; Framingham Heart Study, Framingham, Massachusetts; ; Framingham Heart Study, Framingham, Massachusetts; ; Radiology Department, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; ; Nutritional Epidemiology Program, Jean Mayer U.S. Department of Agriculture Human Nutrition Research Center on Aging, Tufts University, Boston, Massachusetts; ; Nutritional Epidemiology Program, Jean Mayer U.S. Department of Agriculture Human Nutrition Research Center on Aging, Tufts University, Boston, Massachusetts; ; Framingham Heart Study, Framingham, Massachusetts; ; Division of Nephrology and Hypertension, Department of Medicine, University of Miami Miller School; (Diabetes, v.59, 2010, pp.242-248)
-
256
- Residual Disease Monitoring By High Throughput Sequencing Provides Risk Stratification in Childhood B-ALL and Identifies a Novel Subset of Patients Having Poor Outcome
- Wood, Brent L.; Wu, David; Kirsch, Ilan M.; Crossley, Beryl; Williamson, David; Gawad, Charles; Borowitz, Michael J.; Devidas, Meenakshi; Maloney, Kelly W.; Larsen, Eric; Winick, Naomi; Raetz, Elizabeth; Carroll, William L.; Hunger, Stephen P.; Loh, Mignon L.; Robins, Harlan; Departments of Laboratory Medicine and Pathology, University of Washington, Seattle, WA; Department of Laboratory Medicine, University of Washington, Seattle, WA; Adaptive Biotechnologies Corp., Seattle, WA; Adaptive Biotechnologies, Seattle, WA; Adaptive Biotechnology, Seattle, WA; Stanford University, School of Medicine, Palo Alto, CA; Hematologic Pathology, Johns Hopkins University, Baltimore, MD; Department of Biostatistics, College of Medicine, Public Health and Health Professions, University of Florida, Gainesville, FL; Center for Cancer & Blood Disorders, Childrens Hospital Colorado, Aurora, CO; Maine Children's Cancer Program, Scarborough, ME; Pediatric Hematology Oncology, University of Texas Southwestern Medical Center, Dallas, TX; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; Division of Pediatric Hematology Oncology, Department of Pediatrics, Perlmutter Cancer Center, New York University Langone Medical Center, New York, NY; Children's Hosp; (Blood, v.128, 2016, pp.1086-1086)
-
257
- Measurable residual disease detection by high-throughput sequencing improves risk stratification for pediatric B-ALL
- Wood, Brent; Wu, David; Crossley, Beryl; Dai, Yunfeng; Williamson, David; Gawad, Charles; Borowitz, Michael J.; Devidas, Meenakshi; Maloney, Kelly W.; Larsen, Eric; Winick, Naomi; Raetz, Elizabeth; Carroll, William L.; Hunger, Stephen P.; Loh, Mignon L.; Robins, Harlan; Kirsch, Ilan; Department of Laboratory Medicine, University of Washington, Seattle, WA; ; Department of Laboratory Medicine, University of Washington, Seattle, WA; ; Adaptive Biotechnologies, Seattle, WA; ; Department of Biostatistics, University of Florida, Gainesville, FL; ; Adaptive Biotechnologies, Seattle, WA; ; Oncology, St. Jude Children’s Research Hospital, Memphis, TN; ; Oncology, St. Jude Children’s Research Hospital, Memphis, TN; ; Department of Biostatistics, University of Florida, Gainesville, FL; ; University Physicians, Children’s Hospital of Colorado, Aurora, CO; ; Maine Children’s Cancer Center, Scarborough, ME; ; Pediatric Oncology, UT Southwestern, Dallas, TX; ; Pediatric Hematology/Oncology, University of Utah, Salt Lake City, UT; ; Pediatric Oncology, New York University, New York, NY; ; Pediatric Hematology/Oncology, Children’s Hospital of Philadelphia, Philadelphia, PA; ; Pediatric Hematology/Oncology, University of California San Francisco, San Francisco, CA; and; ; (Blood, v.131, 2018, pp.1350-1359)
-
258
- TCR sequencing facilitates diagnosis and identifies mature T cells as the cell of origin in CTCL
- Kirsch, Ilan R.; Watanabe, Rei; O’Malley, John T.; Williamson, David W.; Scott, Laura-Louise; Elco, Christopher P.; Teague, Jessica E.; Gehad, Ahmed; Lowry, Elizabeth L.; LeBoeuf, Nicole R.; Krueger, James G.; Robins, Harlan S.; Kupper, Thomas S.; Clark, Rachael A.; Adaptive Biotechnologies, Seattle, WA 98102, USA.; Department of Dermatology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USA.; Department of Dermatology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USA.; Adaptive Biotechnologies, Seattle, WA 98102, USA.; Department of Dermatology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USA.; Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USA.; Department of Dermatology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USA.; Department of Dermatology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USA.; Department of Dermatology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USA.; Department of Dermatology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USA.; Department of Dermatology, Rockefe; (Science translational medicine, v.7, 2015, pp.308ra158-308ra158)
-
259
- Clinical course and progression-free survival of adult intracranial and spinal ependymoma patients
- Vera-Bolanos, Elizabeth; Aldape, Kenneth; Yuan, Ying; Wu, Jimin; Wani, Khalida; Necesito-Reyes, Mary Jo; Colman, Howard; Dhall, Girish; Lieberman, Frank S.; Metellus, Philippe; Mikkelsen, Tom; Omuro, Antonio; Partap, Sonia; Prados, Michael; Robins, H. Ian; Soffietti, Riccardo; Wu, Jing; Gilbert, Mark R.; Armstrong, Terri S.; ; (Neuro-oncology, v.17, 2015, pp.440-447)
-
260
- Matched T cell repertoire analysis of peripheral blood and tumor-infiltrating lymphocytes (TILs) in early stage breast cancer (ESBC) patients (pts) treated with pre-operative cryoablation (cryo) and/or Ipilimumab (Ipi)
- Page, David B; McArthur, Heather; Dong, Zhiwan; Wong, Phillip; Emerson, Ryan; Mu, Zhenyu; Zhao, Chunjun; Comstock, Christopher; Morris, Elizabeth; Comen, Elizabeth; Kotin, Alan; Sung, Janice; Brogi, Edi; Morrow, Monica; Solomon, Stephen; Sacchini, Virgilio; Maybody, Majid; Neville, Deirdre; Diab, Adi; Sharma, Padmanee; Robins, Harlan; Patil, Sujata; Wolchok, Jedd D; Hudis, Clifford; Norton, Larry; Allison, James; Yuan, Jianda; Memorial Sloan Kettering Cancer Center, New York, NY, USA; Memorial Sloan Kettering Cancer Center, New York, NY, USA; Sloan Kettering Institute, New York, NY, USA; Memorial Sloan Kettering Cancer Center, New York, NY, USA; Adative Biotechnologies, Seattle, WA, USA; Sloan Kettering Institute, New York, NY, USA; Sloan Kettering Institute, New York, NY, USA; Memorial Sloan Kettering Cancer Center, New York, NY, USA; Memorial Sloan Kettering Cancer Center, New York, NY, USA; Memorial Sloan Kettering Cancer Center, New York, NY, USA; Memorial Sloan Kettering Cancer Center, New York, NY, USA; Memorial Sloan Kettering Cancer Center, New York, NY, USA; Memorial Sloan Kettering Cancer Center, New York, NY, USA; Memorial Sloan Kettering Cancer Center, New York, NY, USA; Memorial Sloan Kettering Cancer Center, New York, NY, USA; Memorial Sloan Kettering Cancer Center, New York, NY, USA; Memorial Sloan Kettering Cancer Center, New York, NY, USA; Memorial Sloan Kettering Cancer Cen; (Journal for immunotherapy of cancer, v.2, 2014, pp.P138-P138)
QUICK MENU
